Delaware
|
000-23143
|
13-3379479
|
||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
||
777 Old Saw Mill River Road, Tarrytown, New York
|
10591
|
|||
(Address of principal executive offices)
|
(Zip Code)
|
|||
Registrant's telephone number, including area code (914) 789-2800
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 9.01.
|
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
Press Release issued September 28, 2012.
|
PROGENICS PHARMACEUTICALS, INC.
|
||
By:
|
/s/ ROBERT A. MCKINNEY
|
|
Robert A. McKinney
|
||
Chief Financial Officer, Senior Vice President,
|
||
Finance & Operations
|